Brunsvig P - Search Results

1

Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non-Small Cell Lung Cancer.

Felip E, Barlesi F, Besse B, Chu Q, Gandhi L, Kim SW, Carcereny E, Sequist LV, Brunsvig P, Chouaid C, Smit EF, Groen HJM, Kim DW, Park K, Avsar E, Szpakowski S, Akimov M, Garon EB. Felip E, et al. Among authors: brunsvig p. J Thorac Oncol. 2018 Apr;13(4):576-584. doi: 10.1016/j.jtho.2017.11.131. Epub 2017 Dec 13. J Thorac Oncol. 2018. PMID: 29247830 Free article. Clinical Trial.

2

Palliative thoracic radiotherapy in locally advanced non-small cell lung cancer: can quality-of-life assessments help in selection of patients for short- or long-course radiotherapy?

Sundstrøm S, Bremnes RM, Brunsvig P, Aasebø U, Kaasa S; Norwegian Lung Cancer Study Group. Sundstrøm S, et al. Among authors: brunsvig p. J Thorac Oncol. 2006 Oct;1(8):816-24. J Thorac Oncol. 2006. PMID: 17409965 Free article.

3

Weekly docetaxel with concurrent radiotherapy in locally advanced non-small cell lung cancer: a phase I/II study with 5 years' follow-up.

Brunsvig PF, Hatlevoll R, Berg R, Lauvvang G, Owre K, Wang M, Aamdal S. Brunsvig PF, et al. Lung Cancer. 2005 Oct;50(1):97-105. doi: 10.1016/j.lungcan.2005.05.010. Lung Cancer. 2005. PMID: 16005105 Clinical Trial.

4

Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer.

Brunsvig PF, Aamdal S, Gjertsen MK, Kvalheim G, Markowski-Grimsrud CJ, Sve I, Dyrhaug M, Trachsel S, Møller M, Eriksen JA, Gaudernack G. Brunsvig PF, et al. Cancer Immunol Immunother. 2006 Dec;55(12):1553-64. doi: 10.1007/s00262-006-0145-7. Epub 2006 Feb 21. Cancer Immunol Immunother. 2006. PMID: 16491401 Free PMC article. Clinical Trial.

5

A prospective phase II study: high-dose pemetrexed as second-line chemotherapy in small-cell lung cancer.

Grønberg BH, Bremnes RM, Aasebø U, Brunsvig P, Fløtten O, Amundsen T, von Plessen C, Wang M, Sundstrøm S; Norwegian Lung Cancer Study Group. Grønberg BH, et al. Among authors: brunsvig p. Lung Cancer. 2009 Jan;63(1):88-93. doi: 10.1016/j.lungcan.2008.04.003. Epub 2008 Jun 6. Lung Cancer. 2009. PMID: 18538889 Clinical Trial.

6

Potentially curative radiotherapy for non-small-cell lung cancer in Norway: a population-based study of survival.

Strand TE, Brunsvig PF, Johannessen DC, Sundstrøm S, Wang M, Hornslien K, Bremnes RM, Stensvold A, Garpestad O, Norstein J. Strand TE, et al. Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):133-41. doi: 10.1016/j.ijrobp.2010.01.050. Epub 2010 May 6. Int J Radiat Oncol Biol Phys. 2011. PMID: 20452137

7

Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer.

Brunsvig PF, Guren TK, Nyakas M, Steinfeldt-Reisse CH, Rasch W, Kyte JA, Juul HV, Aamdal S, Gaudernack G, Inderberg EM. Brunsvig PF, et al. Front Immunol. 2020 Nov 26;11:572172. doi: 10.3389/fimmu.2020.572172. eCollection 2020. Front Immunol. 2020. PMID: 33324397 Free PMC article. Clinical Trial.

8

Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.

Sundstrøm S, Bremnes R, Aasebø U, Aamdal S, Hatlevoll R, Brunsvig P, Johannessen DC, Klepp O, Fayers PM, Kaasa S. Sundstrøm S, et al. Among authors: brunsvig p. J Clin Oncol. 2004 Mar 1;22(5):801-10. doi: 10.1200/JCO.2004.06.123. J Clin Oncol. 2004. PMID: 14990635 Clinical Trial.

9

Immediate or delayed radiotherapy in advanced non-small cell lung cancer (NSCLC)? Data from a prospective randomised study.

Sundstrøm S, Bremnes R, Brunsvig P, Aasebø U, Olbjørn K, Fayers PM, Kaasa S; Norwegian Lung Cancer Study Group. Sundstrøm S, et al. Among authors: brunsvig p. Radiother Oncol. 2005 May;75(2):141-8. doi: 10.1016/j.radonc.2005.03.028. Radiother Oncol. 2005. PMID: 16094739 Clinical Trial.

10

Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors.

Spicer J, Marabelle A, Baurain JF, Jebsen NL, Jøssang DE, Awada A, Kristeleit R, Loirat D, Lazaridis G, Jungels C, Brunsvig P, Nicolaisen B, Saunders A, Patel H, Galon J, Hermitte F, Camilio KA, Mauseth B, Sundvold V, Sveinbjørnsson B, Rekdal Ø. Spicer J, et al. Among authors: brunsvig p. Clin Cancer Res. 2021 May 15;27(10):2755-2763. doi: 10.1158/1078-0432.CCR-20-3435. Epub 2021 Feb 4. Clin Cancer Res. 2021. PMID: 33542073 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page